Simmons Bank Abbott Laboratories Transaction History

Simmons Bank

$1.37 Billion
Q3 2024

A detailed history of Simmons Bank transactions in Abbott Laboratories stock. As of the latest transaction made, Simmons Bank holds 37,334 shares of ABT stock, worth $4.38 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

37,334

Previous 39,163 4.67%

Holding current value

$4.38 Million

Previous $4.07 Million 4.6%

% of portfolio

0.31%

Previous 0.31%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$100.07 - $118.13 $183,028 - $216,059	-1,829 Reduced 4.67%	37,334 $4.26 Million
Q2 2024 Jul 26, 2024	SELL	$100.73 - $112.44 $192,797 - $215,210	-1,914 Reduced 4.66%	39,163 $4.07 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $165,375 - $182,649	-1,510 Reduced 3.55%	41,077 $4.67 Million
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $258,755 - $316,737	-2,869 Reduced 6.31%	42,587 $4.69 Million
Q3 2023 Oct 26, 2023	SELL	$95.53 - $114.62 $160,203 - $192,217	-1,677 Reduced 3.56%	45,456 $4.4 Million
Q2 2023 Aug 03, 2023	SELL	$100.78 - $112.29 $256,081 - $285,328	-2,541 Reduced 5.12%	47,133 $5.14 Million
Q1 2023 Apr 28, 2023	SELL	$96.86 - $114.01 $142,577 - $167,822	-1,472 Reduced 2.88%	49,674 $5.03 Million
Q4 2022 Feb 08, 2023	SELL	$95.06 - $111.52 $18,536 - $21,746	-195 Reduced 0.38%	51,146 $5.62 Million
Q3 2022 Oct 27, 2022	SELL	$96.76 - $112.03 $165,169 - $191,235	-1,707 Reduced 3.22%	51,341 $4.97 Million
Q2 2022 Jul 29, 2022	BUY	$102.07 - $123.37 $55,117 - $66,619	540 Added 1.03%	53,048 $5.76 Million
Q1 2022 Apr 21, 2022	SELL	$114.02 - $139.04 $222,567 - $271,406	-1,952 Reduced 3.58%	52,508 $6.22 Million
Q4 2021 Jan 28, 2022	SELL	$115.53 - $141.46 $223,435 - $273,583	-1,934 Reduced 3.43%	54,460 $7.67 Million
Q3 2021 Oct 26, 2021	BUY	$116.66 - $129.06 $120,276 - $133,060	1,031 Added 1.86%	56,394 $6.66 Million
Q2 2021 Aug 05, 2021	SELL	$105.79 - $124.53 $96,797 - $113,944	-915 Reduced 1.63%	55,363 $6.42 Million
Q1 2021 May 06, 2021	SELL	$108.84 - $128.23 $445,264 - $524,588	-4,091 Reduced 6.78%	56,278 $6.74 Million
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $342,090 - $372,780	-3,258 Reduced 5.12%	60,369 $6.61 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $504,111 - $612,206	-5,501 Reduced 7.96%	63,627 $6.93 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $202,144 - $258,720	-2,640 Reduced 3.68%	69,128 $6.32 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $1.65 Million - $2.41 Million	26,290 Added 57.81%	71,768 $5.66 Million
Q4 2019 Jan 31, 2020	SELL	$78.51 - $87.4 $57,233 - $63,714	-729 Reduced 1.58%	45,478 $3.95 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $23,897 - $25,912	-292 Reduced 0.63%	46,207 $3.87 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $34,763 - $40,545	477 Added 1.04%	46,499 $3.91 Million
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $66,153 - $79,979	999 Added 2.22%	46,022 $3.68 Million
Q4 2018 Jan 24, 2019	BUY	$65.56 - $74.27 $45,957 - $52,063	701 Added 1.58%	45,023 $3.26 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $231,746 - $279,574	-3,811 Reduced 7.92%	44,322 $3.25 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $157,108 - $173,400	-2,729 Reduced 5.37%	48,133 $2.98 Million
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $1.5 Million - $1.69 Million	26,577 Added 109.44%	50,862 $3.05 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $71,340 - $76,377	-1,329 Reduced 5.19%	24,285 $1.39 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $78,626 - $87,755	1,636 Added 6.82%	25,614 $1.37 Million
Q2 2017 Aug 15, 2017	BUY	N/A	23,978	23,978 $1.17 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simmons Bank, based on Form 13F filings with the SEC.

News

Stay updated on Simmons Bank with notifications on news.

Account